AMERICAN SHARED HOSPITAL SERVICES
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
AMS$1.22+5.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of cash flows F-
AMERICAN SHARED HOSPITAL SERVICES CONSOLIDATED STATEMENTS OF CASH FLOWS
| YEARS ENDED December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| OPERATING ACTIVITIES | ||
| Net income | $265,000 | $1,555,000 |
| Adjustments to reconcile net income to net cash from operating activities: | ||
| Depreciation and amortization | 5,165,000 | 4,783,000 |
| Non cash lease expense | (34,000) | (40,000) |
| Accretion of deferred issuance costs | 46,000 | 84,000 |
| Loss on write down of impaired assets | 940,000 | — |
| Deferred income taxes | (759,000) | 344,000 |
| Stock-based compensation | 389,000 | 399,000 |
| Changes in operating assets and liabilities: | ||
| Receivables | (719,000) | 696,000 |
| Prepaid expenses and other assets | 21,000 | (111,000) |
| Asset retirement obligations, related party | — | (397,000) |
| Related party liabilities | (491,000) | (845,000) |
| Accounts payable, accrued liabilities and deferred revenue | (79,000) | 608,000 |
| Income taxes payable | 974,000 | 159,000 |
| Net cash provided by operating activities | 5,718,000 | 7,235,000 |
| INVESTING ACTIVITIES | ||
| Payment for purchases of property and equipment | (6,273,000) | (388,000) |
| Net cash (used in) investing activities | (6,273,000) | (388,000) |
| FINANCING ACTIVITIES | ||
| Principal payments on long-term debt | (2,129,000) | (2,032,000) |
| Principal payments on line of credit | (1,400,000) | — |
| Long-term debt financing on purchase of property and equipment | 1,750,000 | — |
| Advances on line of credit | 3,900,000 | — |
| Distributions to non-controlling interests | — | (573,000) |
| Debt issuance costs long-term debt | (9,000) | (9,000) |
| Proceeds from options exercised | — | 5,000 |
| Principal payments on short-term financing prepaid insurance | (202,000) | (48,000) |
| Net cash provided by (used in) financing activities | 1,910,000 | (2,657,000) |
| Net change in cash and cash equivalents | 1,355,000 | 4,190,000 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of year | 12,453,000 | 8,263,000 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of year | $13,808,000 | $12,453,000 |
F- 5
| SUPPLEMENTAL CASH FLOW DISCLOSURE | ||
|---|---|---|
| Cash paid for interest | $1,066,000 | $722,000 |
| Cash paid for income taxes | $297,000 | $169,000 |
| SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES | ||
| Equipment included in accounts payable and accrued liabilities | $1,955,000 | $— |
| DETAIL OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD | ||
| Cash and cash equivalents | $13,690,000 | $12,335,000 |
| Restricted cash | 118,000 | 118,000 |
| Cash, cash equivalents, and restricted cash at end of period | $13,808,000 | $12,453,000 |
F- 6
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.